For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250317:nRSQ9894Aa&default-theme=true
RNS Number : 9894A Haleon PLC 17 March 2025
Haleon plc: Director/PDMR Shareholding
17 March 2025: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today
announces notification and public disclosure in accordance with the
requirements of The UK Market Abuse Regulation of Transactions by a Person
Discharging Managerial Responsibilities ("PDMR").
This notification sets out the details of the vesting of Haleon share awards
over ordinary shares and American Despositary Shares ("ADS") made to PDMRs in
October 2022 under the Haleon Performance Share Plan 2022 and Share Value Plan
2022 and the subsequent sale of ordinary shares and ADS to meet tax
liabilities.
The awards under the Performance Share Plan include dividends accrued and were
conditional on continued employment and on the satisfaction of the performance
conditions over the performance period ended on 31 December 2024 approved by
the Remuneration Committee, which (after tax on the gross award) must be
retained until the shareholding requirement is met, and in any event for
Executive Directors two years after receipt.
The award under the Share Value Plan was conditional on continued employment
and must be retained until the shareholding requirement is met after receipt.
Performance targets and levels of achievement will be disclosed in the 2024
Annual Report and 20-F. All awards are subject to malus and clawback
provisions.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Keith Choy
2 Reason for the notification
a) Position/status President, Asia Pacific
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BMX86B70
b) Nature of the transaction (i) Acquisition of Ordinary Shares in respect of the Haleon plc
Share Value Plan.
(ii) Acquisition of Ordinary Shares in respect of the Haleon plc
Performance Share Plan.
c) Price(s) and volume(s)
Price(s) Volume(s)
(i) Nil 11,196.00
(ii) Nil 574,981.73
d) Aggregated information
- Aggregated volume 586,177.73
- Price N/A
e) Date of the transaction 14 March 2025
f) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Filippo Lanzi
2 Reason for the notification
a) Position/status President, EMEA and LATAM
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BMX86B70
b) Nature of the transaction Acquisition of Ordinary Shares in respect of the Haleon plc Performance Share
Plan.
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil 521,251.16
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 14 March 2025
f) Place of the transaction Outside a trading venue
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BMX86B70
b) Nature of the transaction Automatic disposal of Ordinary Shares resulting from the Haleon plc
Performance Share Plan vesting to cover tax liabilities.
c) Price(s) and volume(s)
Price(s) Volume(s)
£3.868843 239,840.19
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 14 March 2025
f) Place of the transaction London Stock Exchange (XLON)
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Brian McNamara
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BMX86B70
b) Nature of the transaction Acquisition of Ordinary Shares in respect of the Haleon plc Performance Share
Plan.
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil 1,604,522.15
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 14 March 2025
f) Place of the transaction Outside a trading venue
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BMX86B70
b) Nature of the transaction Automatic disposal of Ordinary Shares resulting from the Haleon plc
Performance Share Plan vesting to cover tax liabilities.
c) Price(s) and volume(s)
Price(s) Volume(s)
£3.868843 755,258.30
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 14 March 2025
f) Place of the transaction London Stock Exchange (XLON)
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Lisa Paley
2 Reason for the notification
a) Position/status President, North America
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Haleon plc American Depositary Shares (ADS)
Identification code US4055521003
b) Nature of the transaction Acquisition of ADS in respect of the Haleon plc Performance Share Plan.
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil 289,881.02
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 14 March 2025
f) Place of the transaction Outside a trading venue
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Haleon plc American Depositary Shares (ADS)
Identification code US4055521003
b) Nature of the transaction Automatic disposal of ADS resulting from the Haleon plc Performance Share Plan
vesting to cover tax liabilities.
c) Price(s) and volume(s)
Price(s) Volume(s)
$10.1543 135,511.22
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 14 March 2025
f) Place of the transaction New York Stock Exchange (XNYS)
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Franck Riot
2 Reason for the notification
a) Position/status Chief R&D Officer
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BMX86B70
b) Nature of the transaction Acquisition of Ordinary Shares in respect of the Haleon plc Performance Share
Plan.
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil 393,642.90
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 14 March 2025
f) Place of the transaction Outside a trading venue
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BMX86B70
b) Nature of the transaction Automatic disposal of Ordinary Shares resulting from the Haleon plc
Performance Share Plan vesting to cover tax liabilities.
c) Price(s) and volume(s)
Price(s) Volume(s)
£3.868843 185,290.10
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 14 March 2025
f) Place of the transaction London Stock Exchange (XLON)
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Tamara Rogers
2 Reason for the notification
a) Position/status Chief Marketing Officer
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BMX86B70
b) Nature of the transaction Acquisition of Ordinary Shares in respect of the Haleon plc Performance Share
Plan.
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil 483,987.00
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 14 March 2025
f) Place of the transaction Outside a trading venue
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BMX86B70
b) Nature of the transaction Automatic disposal of Ordinary Shares resulting from the Haleon plc
Performance Share Plan vesting to cover tax liabilities.
c) Price(s) and volume(s)
Price(s) Volume(s)
£3.868843 227,815.61
d) Aggregated information
- Aggregated volume N/A
- Price
e) Date of the transaction 14 March 2025
f) Place of the transaction London Stock Exchange (XLON)
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose
to deliver better everyday health with humanity. Haleon's product portfolio
spans five major categories - Oral Health, Pain Relief, Respiratory Health,
Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its
long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu,
Otrivin, Polident, parodontax and Centrum - are built on trusted science,
innovation and deep human understanding.
For more information, please visit www.haleon.com (http://www.haleon.com/)
.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBUGDXLGBDGUR